SAN CARLOS, Calif., Sept. 4, 2019 /PRNewswire/ -- Apexigen, Inc. announced today the appointment of Scott Smith to its Board of Directors. Mr. Smith joins Apexigen's Board of Directors with over 30 years of managerial and commercial experience in the biotechnology and pharmaceutical industries.

REDWOOD CITY, Calif., Sept. 4, 2019 /PRNewswire/ -- With PCOS Awareness Month upon us, Flo, the number one female health app in the U.S. and 100+ countries with more than 100 million users, today announced it has successfully developed PCOS Health Assistant, a digital self-assessment tool to help identify the risk of polycystic ovary syndrome (PCOS), a widespread women's

CRANFORD, N.J., Sept. 4, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today reported that the FDA responded to the Company's proposal to refine the endpoints in the current Phase 3 pivotal trial for Mino-Lok.The cur

BRIDGEWATER, N.J., Sept. 4, 2019 /PRNewswire/ -- Osmotica Pharmaceuticals plc ("Osmotica" or the "Company") (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced results of the Company's Extraordinary General Meeting. At the Extraordinary General Meeting of the Company held on 29 August 2019, t

SAN DIEGO, Sept. 4, 2019 /PRNewswire/ -- Viriom Inc. (San Diego, CA), has won a grant award in the city of Shaoxing, Zhejiang province, to establish its affiliate in Mainland China. Viriom opened a representative office in Beij

MANHATTAN BEACH, Calif., Sept. 4, 2019 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading patient advocacy organization, announced today that C

NORTH CHICAGO, Ill., Sept. 4, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of September 2, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,773,465 shares of common stock with a par value of $0.0

SEATTLE and VANCOUVER, British Columbia, Sept. 4, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that John Bencich, Chief Financial

ROTTERDAM, Netherlands, Sept. 4, 2019 /PRNewswire/ -- APR Applied Pharma Research s.a. ("APR"), the Swiss pharma company focused in specialized therapeutic areas and rare diseases, presents today at the annual conference of SSIEM (Society for the Study of Inborn Errors in Metabolism) latest scientific data confirming benefits of PKU GOLIKE® in PKU management.

PITTSBURGH, Sept. 4, 2019 /PRNewswire/ -- The City of Pittsburgh, American College of Lifestyle Medicine (ACLM), insurance leader Highmark, and plant-based nutrition company Engine 2 are partnering to launch a month-long cardiovascular health challenge for City of Pittsburgh employees called Heart of a Hero Campaign